Optimizing triage and hospitalization in adult general medical emergency patients: The triage project

BMC Emergency Medicine

Volumn 13, Issue 1, 2013, Pages

  Schuetz, Philipp ^a   Hausfater, Pierre ^a   Amin, Devendra ^h   Haubitz, Sebastian ^a   Fässler, Lukas ^a,g   Grolimund, Eva ^a   Kutz, Alexander ^a   Schild, Ursula ^a   Caldara, Zeljka ^a   Regez, Katharina ^a   Zhydkov, Andriy ^a   Kahles, Timo ^c   Nedeltchev, Krassen ^c   von Felten, Stefanie ^e   De Geest, Sabina ^f   Conca, Antoinette ^c   Schäfer Keller, Petra ^c   Huber, Andreas ^d   Bargetzi, Mario ^c   Buergi, Ulrich ^b   Sauvin, Gabrielle ⁱ   Perrig Chiello, Pasqualina ^g   Reutlinger, Barbara ^c   Mueller, Beat ^a   more..

^a University Department of Medicine   (Switzerland)

^b Kantonsspital Aarau   (Switzerland)

^c University Basel ^*  (Switzerland)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h Morton Plant Hospital   (United States)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Biomarker; Emergency medicine; Manchester triage system; Post acute care needs; Triage

Indexed keywords

ARTICLE; BLOOD SAMPLING; ELECTRONIC MEDICAL RECORD; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FUNCTIONAL STATUS; HEALTH CARE; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; SOCIAL WORKER ATTITUDE; VITAL SIGN;

ADULT; ALGORITHMS; EMERGENCY SERVICE, HOSPITAL; HOSPITALIZATION; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; SWITZERLAND; TRIAGE;

EID: 84879827656     PISSN: None     EISSN: 1471227X     Source Type: Journal    
DOI: 10.1186/1471-227X-13-12     Document Type: Article

References (74)

1. Burt CW, McCaig LF, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2005. Adv Data 2007, 388:1-15.
2. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey emergency department summary. Adv Data 2002, 2004(340):1-34.
3. Puskarich MA, Trzeciak S, Shapiro NI, Heffner AC, Kline JA, Jones AE. Emergency Medicine Shock Research N Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation 2011, 82(10):1289-1293. 10.1016/j.resuscitation.2011.06.015, 3179778, 21752522, Emergency Medicine Shock Research N.
4. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34(6):1589-1596. 10.1097/01.CCM.0000217961.75225.E9, 16625125.
5. Adams HP, Effron MB, Torner J, Davalos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke; a journal of cerebral circulation 2008, 39(1):87-99. 10.1161/STROKEAHA.106.476648, 23878834.
6. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009, 360(26):2705-2718. 10.1056/NEJMoa0808276, 19553646.
7. Christ M, Grossmann F, Winter D, Bingisser R, Platz E. Modern triage in the emergency department. Deutsches Arzteblatt international 2010, 107(50):892-898. 3021905, 21246025.
8. Grossmann FF, Nickel CH, Christ M, Schneider K, Spirig R, Bingisser R. Transporting clinical tools to new settings: cultural adaptation and validation of the Emergency Severity Index in German. Ann Emerg Med 2011, 57(3):257-264. 10.1016/j.annemergmed.2010.07.021, 20952097.
9. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336(4):243-250. 10.1056/NEJM199701233360402, 8995086.
10. Louis Simonet M, Kossovsky MP, Chopard P, Sigaud P, Perneger TV, Gaspoz JM. A predictive score to identify hospitalized patients' risk of discharge to a post-acute care facility. BMC Health Serv Res 2008, 8:154. 10.1186/1472-6963-8-154, 2492858, 18647410.
11. Conca A, Bossart R, Regez K, Schild U, Wallimann G, Schweingruber R, Hantikainen V, Tobias P, Albrich WC, Ruegger K, et al. OPTIMA - Optimierter Patienten-Transfer durch innovatives multidisziplinäres Assessment - Projektbeschreibung der Phase I. PrInterNet - Zeitschrift für Pflegewissenschaft 2012, 14:291-298.
12. Große-Schlarmann J. Der CMS© im ePA©. Verschiedene Qualitätsdimensionen eines Instruments. Eine empirische Analyse 2007, Gelsenkirchen: Private Universität Witten/Herdecke gGmbH.
13. Griffiths P, Wilson-Barnett J. The effectiveness of 'nursing beds': a review of the literature. J Adv Nurs 1998, 27(6):1184-1192. 10.1046/j.1365-2648.1998.00655.x, 9663870.
14. Griffiths PD, Edwards MH, Forbes A, Harris RL, Ritchie G. Effectiveness of intermediate care in nursing-led in-patient units. Cochrane Database Syst Rev 2007, 2:CD002214.
15. Griffiths P, Edwards M, Forbes A, Harris R. Post-acute intermediate care in nursing-led units: a systematic review of effectiveness. Int J Nurs Stud 2005, 42(1):107-116. 10.1016/j.ijnurstu.2004.07.010, 15582644.
16. Harris R, Richardson G, Griffiths P, Hallett N, Wilson-Barnett J. Economic evaluation of a nursing-led inpatient unit: the impact of findings on management decisions of service utility and sustainability. J Nurs Manag 2005, 13(5):428-438. 10.1111/j.1365-2834.2005.00589.x, 16108781.
17. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Muller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium : journal of endothelial cell research 2007, 14(6):345-351.
18. Schuetz P, Wolbers M, Christ-Crain M, Thomann R, Falconnier C, Widmer I, Neidert S, Fricker T, Blum C, Schild U, et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care 2010, 14(3):R106. 10.1186/cc9055, 2911752, 20529344.
19. Renaud B, Schuetz P, Claessens YE, Labarere J, Albrich W, Mueller B. Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia. Chest 2012, 142(6):1447-1454. 10.1378/chest.11-2574, 22661450.
20. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype?. Swiss Med Wkly 2009, 139(23-24):318-326.
21. Schuetz P, Christ-Crain M, Zimmerli W, Mueller B. Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia. Intensive Care Med 2011, 37(6):970-980. 10.1007/s00134-011-2208-2, 21394616.
22. Schuetz P, Jones AE, Aird WC, Shapiro NI. Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock 2011, 36(2):104-108. 10.1097/SHK.0b013e31821e4e04, 3139767, 21522043.
23. Schuetz P, Muller B, Nusbaumer C, Wieland M, Christ-Crain M. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. European journal of endocrinology / European Federation of Endocrine Societies 2009, 160(2):157-163.
24. Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Muller B, Schuetz P. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study. Int J Cardiol 2012, 156(1):16-23. 10.1016/j.ijcard.2010.10.037, 21093937.
25. Schuetz P, Litke A, Albrich WC, Mueller B. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia. Curr Opin Infect Dis 2013, 26(2):159-167.
26. Schuetz P, Haubitz S, Mueller B. Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?. Curr Opin Crit Care 2012, 18(4):341-349. 10.1097/MCC.0b013e328354b2c8, 22610364.
27. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005, 9(6):R816-R824. 10.1186/cc3885, 1414007, 16356231.
28. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010, 55(19):2062-2076. 10.1016/j.jacc.2010.02.025, 20447528.
29. von-Haehling S, Filippatos GS, Papassotiriou J, Cicoira M, Jankowska EA, Doehner W, Rozentryt P, Vassanelli C, Struck J, Banasiak W, et al. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 2010, 12(5):484-491. 10.1093/eurjhf/hfq031, 20215339.
30. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009, 302(1):49-57. 10.1001/jama.2009.943, 3090639, 19567439.
31. Baehni C, Meier S, Spreiter P, Schild U, Regez K, Bossart R, Thomann R, Falconnier C, Christ-Crain M, De-Geest S, et al. Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives. BMC Pulm Med 2010, 10:12. 10.1186/1471-2466-10-12, 2850889, 20222964.
32. Spreiter P, Meier S, Baehni C, Schild U, Regez K, Bossart R, Thomann R, Falconnier C, Christ-Crain M, Muller B, et al. Steps to Take to Reduce Length of Hospital Stay in Patients With Lower Respiratory Tract Infections: A Prospective Cohort Study. Home Health Care Management & Practice 2010, 10:1-8.
33. Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability: " She was probably able to ambulate, but I'm not sure". JAMA 2011, 306(16):1782-1793. 10.1001/jama.2011.1556, 22028354.
34. Albrich WC, Dusemund F, Ruegger K, Christ-Crain M, Zimmerli W, Bregenzer T, Irani S, Buergi U, Reutlinger B, Mueller B, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011, 11:112. 10.1186/1471-2334-11-112, 3119069, 21539743.
35. Albrich WC, Ruegger K, Dusemund F, Bossart R, Regez K, Schild U, Conca A, Schuetz P, Sigrist T, Huber A, et al. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Med Wkly 2011, 141:w13237.
36. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37(1):53-72. 10.1016/0168-8510(96)00822-6, 10158943.
37. Storm-Versloot MN, Ubbink DT, Kappelhof J, Luitse JS. Comparison of an informally structured triage system, the emergency severity index, and the manchester triage system to distinguish patient priority in the emergency department. Academic emergency medicine: official journal of the Society for Academic Emergency Medicine 2011, 18(8):822-829.
38. Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, Huber P, Muller B, Tamm M. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007, 131(1):9-19. 10.1378/chest.06-1500, 17218551.
39. Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schonenberger R, et al. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res 2007, 7:102. 10.1186/1472-6963-7-102, 1947969, 17615073.
40. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174(1):84-93. 10.1164/rccm.200512-1922OC, 16603606.
41. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363(9409):600-607. 10.1016/S0140-6736(04)15591-8, 14987884.
42. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Periat P, Bucher HC, Christ-Crain M. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008, 168(18):2000-2007. discussion 2007-2008, 10.1001/archinte.168.18.2000, 18852401.
43. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302(10):1059-1066. 10.1001/jama.2009.1297, 19738090.
44. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010, 8(5):575-587. 10.1586/eri.10.25, 20455686.
45. Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 2013, 309(7):717-718. 10.1001/jama.2013.697, 23423417.
46. Schuetz P, Muller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012, 9:CD007498.
47. Cals JW, Schot MJ, de-Jong SA, Dinant GJ, Hopstaken RM. Point-of-care C-reactive protein testing and antibiotic prescribing for respiratory tract infections: a randomized controlled trial. Ann Fam Med 2010, 8(2):124-133. 10.1370/afm.1090, 2834719, 20212299.
48. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010, 14(1):R15. 10.1186/cc8872, 2875530, 20144219.
49. Schuetz P, Affolter B, Hunziker S, Winterhalder C, Fischer M, Balestra GM, Hunziker P, Marsch S. Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study. Eur J Clin Invest 2010, 40(4):376-381. 10.1111/j.1365-2362.2010.02259.x, 20192974.
50. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy Collaborative G: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377. 10.1056/NEJMoa010307, 11794169.
51. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson KJ, Milzman D, et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009, 37(1):96-104. 10.1097/CCM.0b013e318192fd9d, 19050610.
52. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, Weiss JW. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005, 45(5):524-528. 10.1016/j.annemergmed.2004.12.006, 15855951.
53. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008, 29(4):452-457. 10.1097/SHK.0b013e31815072c1, 18598002.
54. Shapiro NI, Yano K, Sorasaki M, Fischer C, Shih SC, Aird WC. Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis. J Vasc Res 2009, 46(5):495-502. 10.1159/000210662, 19346756.
55. Schuetz P, Castro P, Shapiro NI. Diabetes and sepsis: preclinical findings and clinical relevance. Diabetes Care 2011, 34(3):771-778. 10.2337/dc10-1185, 3041224, 21357364.
56. Schuetz P, Yano K, Sorasaki M, Ngo L, St Hilaire M, Lucas JM, Aird W, Shapiro NI. Influence of diabetes on endothelial cell response during sepsis. Diabetologia 2011,
57. Schuetz P, Aird W, Jones AE, Shapiro NI. Diabetes is not associated with Increased Mortality in Emergency Department Patients with Sepsis. Ann Emerg Med 2011, in press.
58. Schuetz P, Jones AE, Aird W, Shapiro NI. Endothelial Cell Activation in Emergency Department Patients with Sepsis and Non-sepsis related Hypotension. Shock (Augusta, Ga 2011, in press.
59. Muller B, Morgenthaler N, Stolz D, Schuetz P, Muller C, Bingisser R, Bergmann A, Tamm M, Christ-Crain M. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007, 37(2):145-152. 10.1111/j.1365-2362.2007.01762.x, 17217381.
60. Christ-Crain M, Stolz D, Jutla S, Couppis O, Muller C, Bingisser R, Schuetz P, Tamm M, Edwards R, Muller B, et al. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am J Respir Crit Care Med 2007, 176(9):913-920. 10.1164/rccm.200702-307OC, 17702966.
61. Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Muller B, Schuetz P. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: A prospective validation study. Int J Cardiol 2010, 156(1):16-23.
62. Muller B, Suess E, Schuetz P, Muller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. J Intern Med 2006, 260(6):568-576. 10.1111/j.1365-2796.2006.01722.x, 17116008.
63. Lim WS, van der-Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58(5):377-382. 10.1136/thorax.58.5.377, 1746657, 12728155.
64. Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, Bandinelli S, Phillips CS, Yu B, Connelly S, et al. Red cell distribution width and mortality in older adults: a meta-analysis. The journals of gerontology Series A, Biological sciences and medical sciences 2010, 65(3):258-265. 2822283, 19880817.
65. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007, 50(1):40-47. 10.1016/j.jacc.2007.02.067, 17601544.
66. Braun E, Domany E, Kenig Y, Mazor Y, Makhoul BF, Azzam ZS. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care 2011, 15(4):R194. 10.1186/cc10355, 3387636, 21835005.
67. Shibata H. Nutritional factors on longevity and quality of life in Japan. J Nutr Health Aging 2001, 5(2):97-102.
68. Goebel S, Mehdorn HM. Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 2011, 104(1):357-364. 10.1007/s11060-010-0501-5, 21188470.
69. Lee SJ, Katona LJ, De-Bono SE, Lewis KL. Routine screening for psychological distress on an Australian inpatient haematology and oncology ward: impact on use of psychosocial services. The Medical journal of Australia 2010, 193(5 Suppl):S74-S78.
70. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988, 54(6):1063-1070.
71. Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 2010, 122(1-2):86-95.
72. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008, 54(1):17-23.
73. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27(2):157-172. discussion 207-112, 10.1002/sim.2929, 17569110.
74. Schuetz P, Albrich WC, Suter I, Hug BL, Christ-Crain M, Holler T, Henzen C, Krause M, Schoenenberger R, Zimmerli W, et al. Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia. Swiss Med Wkly 2011, 141:w13228.